Positron emission tomographic imaging of CXCR4 in cancer: challenges and promises

Area of Science:

• Oncology and Molecular Imaging
• Radiochemistry and Nuclear Medicine

Background:

• Molecular imaging facilitates noninvasive cancer detection and assessment.
• C-X-C chemokine receptor 4 (CXCR4) is implicated in tumor metastasis, making it a target for research.
• Targeted imaging of CXCR4 is a rapidly developing field.

Purpose of the Study:

• To review the application of positron emission tomography (PET) for characterizing C-X-C chemokine receptor 4 (CXCR4) expression.
• To provide insights into the chemical, radiosynthetic, and biological requirements for CXCR4-targeting PET radiotracers.
• To summarize current approaches and compare their clinical translation.

Main Methods:

• Literature review focusing on PET imaging of CXCR4.
• Analysis of chemical, radiosynthetic, and biological aspects of PET radiotracers.
• Comparison of different imaging approaches and their clinical utility.

Main Results:

• Detailed overview of PET radiotracers developed for CXCR4 imaging.
• Assessment of the challenges and successes in clinical translation.
• Identification of key requirements for effective CXCR4-targeted PET agents.

Conclusions:

• PET is a valuable tool for assessing CXCR4 expression in cancer.
• Radiotracer development requires careful consideration of chemical, synthetic, and biological factors.
• Future advances are expected to improve the clinical application of CXCR4-targeted PET imaging for cancer management.